Disruption of KV2.1 somato-dendritic clusters prevents the apoptogenic increase of potassium currents

Neuroscience. 2017 Jun 23:354:158-167. doi: 10.1016/j.neuroscience.2017.04.034. Epub 2017 Apr 28.

Abstract

As the predominant mediator of the delayed rectifier current, KV2.1 is an important regulator of neuronal excitability. KV2.1, however, also plays a well-established role in apoptotic cell death. Apoptogenic stimuli induce syntaxin-dependent trafficking of KV2.1, resulting in an augmented delayed rectifier current that acts as a conduit for K+ efflux required for pro-apoptotic protease/nuclease activation. Recent evidence suggests that KV2.1 somato-dendritic clusters regulate the formation of endoplasmic reticulum-plasma membrane junctions that function as scaffolding sites for plasma membrane trafficking of ion channels, including KV2.1. However, it is unknown whether KV2.1 somato-dendritic clusters are required for apoptogenic trafficking of KV2.1. By overexpression of a protein derived from the C-terminus of the cognate channel KV2.2 (KV2.2CT), we induced calcineurin-independent disruption of KV2.1 somato-dendritic clusters in rat cortical neurons, without altering the electrophysiological properties of the channel. We observed that KV2.2CT-expressing neurons are less susceptible to oxidative stress-induced cell death. Critically, expression of KV2.2CT effectively blocked the increased current density of the delayed rectifier current associated with oxidative injury, supporting a vital role of KV2.1-somato-dendritic clusters in apoptogenic increases in KV2.1-mediated currents.

Keywords: K(V)2.1; apoptosis; oxidative stress; potassium channel; syntaxin; zinc.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / genetics*
  • Apoptosis / physiology
  • Cells, Cultured
  • Cerebral Cortex / cytology
  • Cholinesterase Inhibitors / pharmacology
  • Cricetulus
  • Dendrites / genetics
  • Dendrites / metabolism*
  • Embryo, Mammalian
  • Enzyme Inhibitors / pharmacology
  • Ethylenediamines / pharmacology
  • Female
  • Immunosuppressive Agents / pharmacology
  • Membrane Potentials / drug effects
  • Membrane Potentials / genetics
  • Microglia / metabolism
  • Neurons / cytology*
  • Neurons / physiology
  • Pregnancy
  • Pyridines / toxicity
  • Rats
  • Shab Potassium Channels / genetics
  • Shab Potassium Channels / metabolism*
  • Tacrolimus / analogs & derivatives
  • Tacrolimus / pharmacology

Substances

  • Cholinesterase Inhibitors
  • Enzyme Inhibitors
  • Ethylenediamines
  • Immunosuppressive Agents
  • Pyridines
  • Shab Potassium Channels
  • 2,2'-dithiobis(5-nitropyridine)
  • immunomycin
  • N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine
  • Tacrolimus